ERBB4 and amyotrophic lateral sclerosis: Reduced ERBB4 immunoreactivity in spinal cord tissues has been shown to correlate with the severity of motor neuron degeneration and the mislocalization of TDP-43 in postmortem studies of ALS patients (Takahashi et al., 2019).